Reduced dose fludarabine and cyclophosphamide lymphodepletion before tumor-infiltrating lymphocyte therapy in melanoma

Authors

Institutions

Publication Details

Journal
Future Oncology
Published
2025-05-09
DOI
https://doi.org/10.1080/14796694.2025.2498842
Citations
1
Primary Topic
Immunotherapy and Immune Responses
Type
article
Field-Weighted Citation Impact
0.80
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Reduced dose fludarabine and cyclophosphamide lymphodepletion before tumor-infiltrating lymphocyte therapy in melanoma

Haitham Abdelhakim, Muhammad Umair Mushtaq, Joseph P. McGuirk, Luke V. Selby et al.
1 citations
Future Oncology
Immunotherapy and Immune Responses
0.80
article

Reduced dose fludarabine and cyclophosphamide lymphodepletion before tumor-infiltrating lymphocyte therapy in melanoma

Haitham Abdelhakim, Muhammad Umair Mushtaq, Joseph P. McGuirk, Luke V. Selby, Gary C. Doolittle, Sunil Abhyankar, Moazzam Shahzad
article en
1 citations

Abstract

No abstract available for this paper.
Future OncologyVol. 21(13)
University of Kansas Medical Center (US)
Good health and well-being
Openalex Percentile: Top 28%
Immunotherapy and Immune Responses
0.80
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.